Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the period 2016 – 2025.
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample
The drugs candidates that are being developed by the different pharmaceutical companies have demonstrated positive clinical trial results which in-turn increase their further development. For instance, in May 2017 OMS721, a drug candidate developed by the Omeros Corporation demonstrated positive clinical trial results in the treatment of patients with IgA nephropathy. In December 2016, Anthera Pharmaceuticals, Inc. presented positive clinical trial results of blisibimod in 48-week, Phase II study in the treatment of patients with IgA nephropathy.
Companies are developing drugs with promising targets for the treatment of the disease. The potential targets may possibly stop or slow the progression of the disease with better efficacy and less side effects. Potential targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS), melanocortin receptors, and NF-κB signaling can also prove to be effective in IgA nephropathy treatment, since clinical trials of drug candidates meant to act on these targets have shown promising results. This is encouraging companies to further invest in their pipeline to develop drugs acting on new targets, thereby, fueling the growth of the pipeline.
Various new technologies are being used by the companies for the development of drugs to treat IgA nephropathy. For instance, TARGIT drug delivery technology is being used by Calliditas Therapeutics AB for the development of novel drug therapies.
Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=iga-nephropathy-pipeline-analysis
Some of the key players developing drugs for the treatment of IgA nephropathy include Mallinckrodt plc, Merck KGaA, Novartis AG, and Shire plc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline here
News-ID: 1108877 • Views: 1029
More Releases from P&S Market Research - Pharmaceuticals
Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of
Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market As per the findings of research, it
Arthritis Therapeutics Pipeline Analysis, Clinical Trials & Results, Patent and …
Arthritis is an inflammatory disorder that occurs in joints and surrounding tissues. There are six types of arthritis namely osteoarthritis, autoimmune arthritis, psoriatic arthritis, juvenile arthritis, gout arthritis, and infectious arthritis. Symptoms of arthritis can include pain, swelling, redness, stiffness and decrease in movement. Some of the risk factors associated with arthritis are aging, obesity, joint injury, and family history. Certain laboratory tests such as blood test, and urine test,
More Releases for IgA
Identity Governance and Administration (IGA) Market Trends, Analysis by Regions, …
Identity Governance and Administration (IGA) is commonly defined as the policy-based centralized set up of user identity management and access control. Identity governance and Administration helps support enterprise IT security and regulatory compliance. Due to increase in adoption of identity governance in the organization it is expected that Identity Governance and Administration (IGA) market will grow in the recent times. The rising advent of globalization and the rise in regulatory compliances
IgA Nephropathy Therapeutics Analysis by Key Players Mallinckrodt Pharmaceutical …
The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the period 2016 – 2025. Browse report sample at: https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis/report-sample *Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline Various new technologies are being used by the companies for the development of drugs to treat IgA nephropathy. For instance, TARGIT drug
Identity Management Software Market Growth Attributed to Novel Breakthrough in I …
Emergence of hybrid IT environment across enterprises has necessitated adoption of identity management software system for enforcing authorized access to network applications, favoring secure enterprise data access and security. Novel development in identity governance and administration is attributed as chief growth enabler in identity management software market. In a recently added research report, ‘Global Identity Management Software Market Size, Status and Forecast 2018-2025’, Market Research Hub (MRH) collates core developments and
North America has been the Largest Global Identity Governance and Administration …
Global IGA market is on the rise due to increasing demand from enterprises to identify their users, control whatever they can access, and further audit their activities for security of information. Apart from this, since IGA also provides businesses with numerous supplementary functions, including auditing and policy management, its adoption by business leaders across industries, is expected to escalate in near future. The global IGA market is segmented on the
IgA Nephropathy Exhibits Emerging Pipeline with 11+ Drug Candidates
The study analyzed that the IgA nephropathy pipeline comprises of 12 drug candidates, of which one drug candidate is in Phase III stage, five drug candidates are in Phase II stage and three drug candidates are in Pre-Clinical stage. Also, there are two inactive drug candidates and one discontinued drug candidate. IgA nephropathy, also known as Berger’s disease, is a kidney disorder that occurs when IgA antibody gets settled in
IVU app keeps IGA visitors informed
IVU supplies guidance and information system for IGA 2017 Berlin, 4 April 2017 – This year’s International Garden Show will draw crowds to Berlin with flowers, indoor and outdoor exhibitions and events. An app created by IVU Traffic Technologies AG on behalf of the state of Berlin will help visitors to find their way around the site and discover the various attractions. The application also meets the special requirements of people